Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1

European Journal of Heart Failure

Volumn 9, Issue 1, 2007, Pages 15-22

  Ye, Lei ^a   Haider, Husnain Kh ^a   Jiang, Shujia ^b   Tan, Ru San ^b   Ge, Ruowen ^a   Law, Peter K ^c   Sim, Eugene K W ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c Cell Transplants International LLC   (United States)

Author keywords

Angiogenesis; Gene therapy; Infarction; Skeletal myoblast

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; BETA GALACTOSIDASE; MICROSPHERE; SMOOTH MUSCLE ACTIN; VASCULOTROPIN 165; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BASED GENE THERAPY; CELL SURVIVAL; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GENE; GENETIC TRANSDUCTION; HEART BLOOD VESSEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TISSUE SECTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VIRAL GENE DELIVERY SYSTEM; Y CHROMOSOME;

ADENOVIRIDAE; ANGIOPOIETIN-1; ANIMALS; BIOPSY; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DNA PRIMERS; ELECTROCARDIOGRAPHY; FEMALE; GENETIC VECTORS; HUMANS; MALE; MUSCLE, SKELETAL; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846102433     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.04.008     Document Type: Article

References (28)

1. Freedman S.B., and Isner J.M. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136 (2002) 54-71
2. Lopez J.J., Laham R.J., Stamler A., et al. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 40 (1998) 272-281
3. Suri C., McClain J., Thurston G., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
4. Duan H.F., Wu C.T., Wu D.L., et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells over expressing hepatocyte growth factor. Mol Ther 8 (2003) 467-474
5. 165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102 (2002) 965-974
6. Henry T.D., Annex B.H., McKendall G.R., and VIVA Investigators. The VIVA trials VEGF in ischemia for vascular angiogenesis. Circulation 107 (2003) 1359-1365
7. Simons M., Bonow R.O., Chronos N.A., et al. Clinical trials in coronary angiogenesis: issues, problems consensus. Circulation 102 (2000) e73-e86
8. de Felipe P. Polycistronic viral vectors. Curr Gene Ther 2 (2002) 355-378
9. Tsuchiyama T., Kaneko S., Nakamoto Y., et al. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemo-attractant protein-1 against hepatocellular carcinomas. Cancer Gene Ther 10 (2003) 260-269
10. Ciafre S.A., Barillari G., Bongiorno-Borbone L., Wannenes F., Izquierdo M., and Farace M.G. A tricistronic retroviral vector expressing natural anti-angiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo. Gene Ther 9 (2002) 297-302
11. Shyu K.-G., Chang H., and Isner J.M. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neo-angiogenesis in hyper-cholesterolemic rabbit model with acute hind limb ischemia. Life Sci 73 (2003) 563-579
12. Jones M.K., Kawanaka H., Baatar D., et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterol 121 (2001) 1040-1047
13. Arsic N., Zentilin L., Zacchigna S., et al. Induction of functional neovascularization by combined VEGF165 and Ang-1gene transfer using rAAV vectors. Mol Ther 7 (2003) 450-459
14. Schalch P., Rahman G.F., Patejunas G., et al. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state. J Thorac Cardiovasc Surg 127 (2004) 535-540
15. Xiao L., Liu P., Sobue T., Lichtler A., Coffin J.D., and Hurley M.M. Effect of over expressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cells. J Cell Biochem 89 (2003) 1291-1301
16. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 (2000) 898-901
17. Schwarz E.R., Speakman M.T., Patterson M., et al. Evaluation of intramyocardial injection of DNA expressing VEGF in MI model in rat angiogenesis or angioma formation. J Am Coll Cardiol 35 (2000) 1323-1330
18. Cao R., Brakenhielm E., and Pawliuk R. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9 (2003) 604-613
19. Kim I., Moon S.O., Park S.K., Chae S.W., and Koh G.Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to the endothelial cells by reducing ICAM, VCAM, and E-selectin expression. Circ Res 89 (2001) 477-479
20. Chae J.K., Kim I., Lim S.T., et al. Co-administration of angiopoietin-1 and VEGF enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20 (2000) 2573-2578
21. Ferrara N. VEGF and the regulation of angiogenesis. Recent Prog Horm Res 55 (2000) 15-36
22. Koh G.Y., Kim I., Kwak H.J., Yun M.J., and Leem J.C. Biomedical significance of endothelial cell specific growth factor, angiopoietin. Exp Mol Med 34 (2002) 1-11
23. Thurston G., Suri C., Smith K., et al. Leakage resistant blood vessels in mice transgenically over expressing Ang-I. Science 286 (1999) 2511-2514
24. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., and Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104 (2001) I218-I222
25. Suzuki K., Murtuza B., Smolenski R.T., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 (2001) I207-I212
26. Haider HKh., Ye L., Jiang S., et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 82 (2004) 539-549
27. Kay M.A., Glorioso J.C., and Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles for therapeutics. Nat Med 7 (2001) 33-40
28. Haider HKh., Jiang S.J., Ye L., Aziz S., Law P.K., and Sim E.K.W. Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplant Proc 36 (2004) 232-235